Glanzmann's thrombasthenia screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{{Glanzmann's thrombasthenia}} | {{Glanzmann's thrombasthenia}} | ||
{{CMG}} | {{CMG}} {{AE}} {{OK}} | ||
==Overview== | ==Overview== |
Revision as of 23:41, 15 November 2018
Glanzmann's thrombasthenia |
Differentiating Glanzmann's thrombasthenia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glanzmann's thrombasthenia screening On the Web |
American Roentgen Ray Society Images of Glanzmann's thrombasthenia screening |
Risk calculators and risk factors for Glanzmann's thrombasthenia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]
Overview
According to the United States Preventive Services Task Force, screening for Glanzmann's thrombasthenia is not recommended.
Screening
According to the United States Preventive Services Task Force, screening for Glanzmann's thrombasthenia is not recommended.